位置:首页 > 蛋白库 > ZHX1_MOUSE
ZHX1_MOUSE
ID   ZHX1_MOUSE              Reviewed;         873 AA.
AC   P70121; Q8BQ68; Q8C6T4; Q8CJG3;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-FEB-2004, sequence version 2.
DT   03-AUG-2022, entry version 178.
DE   RecName: Full=Zinc fingers and homeoboxes protein 1;
GN   Name=Zhx1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090 {ECO:0000312|EMBL:CAA90905.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Bone marrow stroma {ECO:0000269|PubMed:8713137};
RX   PubMed=8713137; DOI=10.1006/bbrc.1996.1114;
RA   Barthelemy I., Carramolino L., Gutierrez J., Barbero J.L., Marquez G.,
RA   Zaballos A.;
RT   "zhx-1: a novel mouse homeodomain protein containing two zinc-fingers and
RT   five homeodomains.";
RL   Biochem. Biophys. Res. Commun. 224:870-876(1996).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=129/SvJ {ECO:0000312|EMBL:BAC22110.1};
RX   PubMed=12527199; DOI=10.1016/s0378-1119(02)01093-4;
RA   Shou Z., Yamada K., Inazu T., Kawata H., Hirano S., Mizutani T., Yazawa T.,
RA   Sekiguchi T., Yoshino M., Kajitani T., Okada K., Miyamoto K.;
RT   "Genomic structure and analysis of transcriptional regulation of the mouse
RT   zinc-fingers and homeoboxes 1 (ZHX1) gene.";
RL   Gene 302:83-94(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Lung, and Spinal ganglion;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:AAH54543.1};
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH54543.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5] {ECO:0000305}
RP   INDUCTION.
RX   PubMed=14741719; DOI=10.1016/j.bbrc.2003.12.162;
RA   Shou Z., Yamada K., Kawata H., Yokoyama O., Miyamoto K.;
RT   "A mechanism of induction of the mouse zinc-fingers and homeoboxes 1 (ZHX1)
RT   gene expression by interleukin-2.";
RL   Biochem. Biophys. Res. Commun. 314:885-890(2004).
RN   [6]
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Kidney;
RX   PubMed=17056598; DOI=10.1074/jbc.m606664200;
RA   Liu G., Clement L.C., Kanwar Y.S., Avila-Casado C., Chugh S.S.;
RT   "ZHX proteins regulate podocyte gene expression during the development of
RT   nephrotic syndrome.";
RL   J. Biol. Chem. 281:39681-39692(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-45; SER-47 AND SER-48, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-48 AND SER-648, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Kidney, Lung, and Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Acts as a transcriptional repressor. Increases DNMT3B-
CC       mediated repressive transcriptional activity when DNMT3B is tethered to
CC       DNA. May link molecule between DNMT3B and other co-repressor proteins
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Forms homodimers. Heterodimer (via HD1 domain) with ZHX2 (via
CC       HD1 domain). Also forms a heterodimer with ZHX3 which is a prerequisite
CC       for repressor activity. Interacts with ATF7IP and NFYA. Interacts (via
CC       homeobox domains) with DNMT3B (via PWWP domain) (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00108,
CC       ECO:0000269|PubMed:17056598}. Note=Colocalized in the nucleus with
CC       DNMT3B. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in brain.
CC       {ECO:0000269|PubMed:8713137}.
CC   -!- INDUCTION: By interleukin-2. {ECO:0000269|PubMed:14741719}.
CC   -!- SIMILARITY: Belongs to the ZHX family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z54200; CAA90905.1; -; mRNA.
DR   EMBL; AB078421; BAC22110.1; -; Genomic_DNA.
DR   EMBL; AK051410; BAC34629.1; -; mRNA.
DR   EMBL; AK053191; BAC35306.1; -; mRNA.
DR   EMBL; BC054543; AAH54543.1; -; mRNA.
DR   CCDS; CCDS27488.1; -.
DR   PIR; JC4863; JC4863.
DR   RefSeq; NP_001035903.1; NM_001042438.2.
DR   RefSeq; NP_033598.2; NM_009572.4.
DR   AlphaFoldDB; P70121; -.
DR   SMR; P70121; -.
DR   BioGRID; 204693; 1.
DR   IntAct; P70121; 1.
DR   MINT; P70121; -.
DR   STRING; 10090.ENSMUSP00000066201; -.
DR   iPTMnet; P70121; -.
DR   PhosphoSitePlus; P70121; -.
DR   EPD; P70121; -.
DR   jPOST; P70121; -.
DR   MaxQB; P70121; -.
DR   PaxDb; P70121; -.
DR   PeptideAtlas; P70121; -.
DR   PRIDE; P70121; -.
DR   ProteomicsDB; 302059; -.
DR   Antibodypedia; 26954; 169 antibodies from 24 providers.
DR   DNASU; 22770; -.
DR   Ensembl; ENSMUST00000070143; ENSMUSP00000066201; ENSMUSG00000022361.
DR   Ensembl; ENSMUST00000110168; ENSMUSP00000105797; ENSMUSG00000022361.
DR   Ensembl; ENSMUST00000175805; ENSMUSP00000134844; ENSMUSG00000022361.
DR   GeneID; 22770; -.
DR   KEGG; mmu:22770; -.
DR   UCSC; uc007vtd.2; mouse.
DR   CTD; 11244; -.
DR   MGI; MGI:109271; Zhx1.
DR   VEuPathDB; HostDB:ENSMUSG00000022361; -.
DR   eggNOG; ENOG502QT3D; Eukaryota.
DR   GeneTree; ENSGT00950000182893; -.
DR   InParanoid; P70121; -.
DR   OMA; HSVVCSA; -.
DR   OrthoDB; 518562at2759; -.
DR   PhylomeDB; P70121; -.
DR   TreeFam; TF333363; -.
DR   BioGRID-ORCS; 22770; 2 hits in 75 CRISPR screens.
DR   ChiTaRS; Zhx1; mouse.
DR   PRO; PR:P70121; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; P70121; protein.
DR   Bgee; ENSMUSG00000022361; Expressed in undifferentiated genital tubercle and 75 other tissues.
DR   ExpressionAtlas; P70121; baseline and differential.
DR   Genevisible; P70121; MM.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; ISO:MGI.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:MGI.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; ISO:MGI.
DR   CDD; cd00086; homeodomain; 5.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR024578; Homez_homeobox_dom.
DR   InterPro; IPR041057; ZHX_Znf_C2H2.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00046; Homeodomain; 4.
DR   Pfam; PF11569; Homez; 1.
DR   Pfam; PF18387; zf_C2H2_ZHX; 1.
DR   SMART; SM00389; HOX; 5.
DR   SMART; SM00355; ZnF_C2H2; 2.
DR   SUPFAM; SSF46689; SSF46689; 5.
DR   SUPFAM; SSF57667; SSF57667; 2.
DR   PROSITE; PS50071; HOMEOBOX_2; 4.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   1: Evidence at protein level;
KW   DNA-binding; Homeobox; Isopeptide bond; Metal-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..873
FT                   /note="Zinc fingers and homeoboxes protein 1"
FT                   /id="PRO_0000049389"
FT   ZN_FING         70..93
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042,
FT                   ECO:0000305"
FT   ZN_FING         102..125
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042,
FT                   ECO:0000305"
FT   DNA_BIND        284..346
FT                   /note="Homeobox 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108,
FT                   ECO:0000305"
FT   DNA_BIND        464..526
FT                   /note="Homeobox 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108,
FT                   ECO:0000305"
FT   DNA_BIND        569..630
FT                   /note="Homeobox 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108,
FT                   ECO:0000305"
FT   DNA_BIND        660..722
FT                   /note="Homeobox 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108,
FT                   ECO:0000305"
FT   DNA_BIND        777..832
FT                   /note="Homeobox 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108,
FT                   ECO:0000305"
FT   REGION          41..63
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          198..247
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          272..564
FT                   /note="Required for interaction with NFYA"
FT                   /evidence="ECO:0000250"
FT   REGION          272..432
FT                   /note="Required for dimerization"
FT                   /evidence="ECO:0000250"
FT   REGION          429..456
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          541..568
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          627..668
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          731..767
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          734..768
FT                   /note="Required for nuclear localization"
FT                   /evidence="ECO:0000250"
FT   REGION          829..873
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          831..873
FT                   /note="Required for repressor activity"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        44..63
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        198..217
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        218..247
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        429..447
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        549..564
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        627..648
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        742..762
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        831..855
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        856..873
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         36
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKY1"
FT   MOD_RES         45
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355"
FT   MOD_RES         47
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         48
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         202
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKY1"
FT   MOD_RES         648
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         774
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKY1"
FT   CROSSLNK        159
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKY1"
FT   CROSSLNK        441
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKY1"
FT   CROSSLNK        485
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKY1"
FT   CROSSLNK        629
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UKY1"
FT   CONFLICT        375
FT                   /note="S -> T (in Ref. 1 and 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        388
FT                   /note="C -> Y (in Ref. 3; BAC34629)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        553
FT                   /note="A -> R (in Ref. 1; CAA90905)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        867..868
FT                   /note="KL -> NV (in Ref. 1; CAA90905)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   873 AA;  97551 MW;  98C5D5714D479364 CRC64;
     MASRRKSTTP CMVLASEQDP DLELISDLDE GPPILTPVEN AKAESVSSDE EVHGSVDSDN
     QQNKKVEGGY ECKYCTFQTP DLNMFTFHVD SEHPNVVLNS SYVCVECNFL TKRYDALSEH
     NLKYHPGEEN FKLTMVKRNN QTIFEQTIND LTFDGSFVKE ENTEQGESID VSSSGISISK
     TPIMKMMKNK VENKRITVHH NSAEGTSEEK ENGVKASQEE NAESVSSSAL ESNTSTSTIN
     RVHPSPASTV VTPTAVLPGL AQVITAVSAQ QNSNLLPKVL IPVNSIPTYN AALDNNPLLL
     NTYNKFPYPT MSEITVLSAQ AKYTEEQIKI WFSAQRLKHG VSWTPEEVEE ARRKQFNGTV
     HTVPQTITVI PTHISTGSNG LPSILQTCQI VGQPGLVLTQ VAGTNTLPVT APIALTVAGV
     PNQTNVQKSQ VPAAQPATDT KPATAAVPSS PSVRPEAALV NPDSFGIRAK KTKEQLAELK
     VSYLKNQFPH DSEIIRLMKI TGLTKGEIKK WFSDTRYNQR NSKSNQCLHL NNDSSATIII
     DSSDETPEPP AAAASQQKQS WNPFPDFAPQ KFKEKTAEQL RALQASFLNS SVLTDEEVNR
     LRAQTKLTRR EIDAWFTEKN KTKALKDEKI EVDESNVGSS KEEPGESSPG DETVAPKSGG
     TGKICKKTPE QLHMLKSAFV RTQWPSAEEY DKLAEESGLA RTDIVSWFGD TRYAWKNGNL
     KWYYYYQSSN SSSLNGLSSL RRRGRGRPKG RGRGRPRGRP RGGKRMNTWD RVPSLIKFKT
     GTAILKDYYL KHKFLNEQDL DELVNRSHMG YEQVREWFAE RQRRSELGIE LFEENEEEDE
     VVDDQEEDEE ETDDSDTWEP PRHVKRKLSK SDD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024